澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

4DMEDICAL LTD

3.740

+0.3008.72%

成交量：528.71萬

成交額：1,931.42萬

市值：22.50億

市盈率：-10.93

高：3.760

開：3.520

低：3.490

收：3.440

52周最高：7.550

52周最低：1.400

股本：6.02億

流通股本：3.78億

量比：1.71

換手率：1.40%

股息：- -

股息率：- -

每股收益(TTM):-0.342

每股收益(LYR):-0.342

淨資產收益率：-174.43%

總資產收益率：-15.62%

市淨率：13.22

市盈率(LYR):-10.93

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

4DMedical獲澳大利亞TGA批准CTVQ技術

異動解讀 | 4DMedical推出臨床證據計劃，股價盤中大漲5.38%

4DMedical推出明確臨床證據計劃，旨在加速Ct:Vq™進入急性肺栓塞市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/4DX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.74,"timestamp":1789452720000,"preClose":3.44,"halted":0,"volume":5287057,"delay":0,"changeRate":0.08720930232558148,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":601571602,"eps":-0.342118,"marketStatus":"未開盤","change":0.3,"latestTime":"09-15 16:12:00 AEST","open":3.52,"high":3.76,"low":3.49,"amount":19314152,"amplitude":0.078488,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.342118,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.44,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":1.7112871815111528,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":3.74,"auctionPrice":3.74,"auctionVolume":6941,"auctionTime":1789511711477,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789511711477}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-15.62%","roe":"-174.43%","lyrEps":-0.342118,"volumeRatio":1.7112871815111528,"shares":601571602,"dividePrice":0,"high":3.76,"amplitude":0.078488,"preClose":3.44,"low":3.49,"week52Low":1.4,"pbRate":"13.22","psRate":"318.61","week52High":7.55,"institutionHeld":0,"latestPrice":3.74,"eps":-0.342118,"divideRate":0,"volume":5287057,"delay":0,"ttmEps":-0.342118,"open":3.52,"prevYearClose":3.93,"prevWeekClose":3.36,"prevMonthClose":3.42,"prevQuarterClose":4.53,"fiveDayClose":3.35,"twentyDayClose":3.76,"sixtyDayClose":4.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127775213","title":"4DMedical獲澳大利亞TGA批准CTVQ技術","url":"https://stock-news.laohu8.com/highlight/detail?id=1127775213","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127775213?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 09:37","pubTimestamp":1782437859,"startTime":"0","endTime":"0","summary":"4DMedical Ltd宣布，其CTVQ技术已获得澳大利亚治疗商品管理局的批准。这一监管进展为该公司在澳大利亚市场的业务拓展奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149159643","title":"異動解讀 | 4DMedical推出臨床證據計劃，股價盤中大漲5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149159643","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149159643?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 08:03","pubTimestamp":1780358589,"startTime":"0","endTime":"0","summary":"4DMedical有限公司（股票代码：4DX.AU）今日盘中大涨5.38%，引起了市场的关注。消息面上，公司宣布启动一项明确的临床证据计划，该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞（PE）市场铺平道路，这被视为一项积极的业务进展，增强了投资者对公司未来增长潜力的信心。该临床证据计划的核心目标是通过生成坚实的临床数据，来支持这项创新技术在关键医疗领域的应用与采纳，市场预期此举将有助于公司拓展新的市场机会。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146205447","title":"4DMedical推出明確臨床證據計劃，旨在加速Ct:Vq™進入急性肺栓塞市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1146205447","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146205447?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 06:32","pubTimestamp":1780353139,"startTime":"0","endTime":"0","summary":"4DMedical有限公司宣布启动一项明确的临床证据计划，该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞（PE）市场铺平道路。该计划的核心目标是通过生成坚实的临床数据，来支持这项创新技术在关键医疗领域的应用与采纳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/4DX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}